What is the recommended next work‑up and treatment for a patient with epigastric pain and bloating, denying constipation, who has been on omeprazole (a proton pump inhibitor) since [date]?

Management of Refractory Dyspepsia on Omeprazole

Since this patient has persistent epigastric pain and bloating despite ongoing omeprazole therapy, the next step is to test for Helicobacter pylori infection and, if positive, provide eradication therapy; if negative or symptoms persist after eradication, initiate a tricyclic antidepressant such as amitriptyline 10 mg once daily as second-line treatment. 1

Diagnostic Workup

The 2022 British Society of Gastroenterology guidelines provide clear direction for patients failing PPI therapy 1:

• Test for H. pylori immediately if not already done. This is a strong recommendation with high-quality evidence. Eradication therapy is efficacious for H. pylori-positive functional dyspepsia patients 1

• Do NOT routinely order gastric emptying studies or 24-hour pH monitoring in patients with typical dyspepsia symptoms—these tests add no value 1

• Consider referral to gastroenterology if there is diagnostic uncertainty, severe symptoms, or symptoms refractory to first-line treatments 1

Red Flags Requiring Urgent Endoscopy

While not explicitly mentioned in your case, ensure this patient does NOT have alarm features that would mandate immediate endoscopy regardless of H. pylori status. These include unintentional weight loss, progressive dysphagia, persistent vomiting, evidence of GI bleeding, or palpable abdominal mass.

Treatment Algorithm

Step 1: H. pylori Testing and Eradication

If H. pylori testing is positive:

• Bismuth quadruple therapy for 14 days is the preferred first-line regimen 2:

  • Bismuth subsalicylate (e.g., Pepto-Bismol) 2 tablets QID 30 minutes before meals
  • Tetracycline 500 mg QID 30 minutes after meals
  • Metronidazole 500 mg QID 30 minutes after meals
  • PPI (omeprazole 40 mg or equivalent) BID 30 minutes before meals

• Alternative regimens exist but should only be used if local susceptibility data confirms >90% cure rates 2

Step 2: Optimize PPI Therapy (If Not Already Done)

The current omeprazole regimen may be suboptimal 3:

• Ensure proper dosing: For functional dyspepsia, omeprazole 20 mg once daily is standard, but can be increased to 40 mg once daily if needed 3

• Verify timing: Omeprazole must be taken before meals for optimal efficacy 3

• Consider PPI potency: If cost-equivalent, switching to rabeprazole 20 mg or esomeprazole 20 mg BID may provide better acid suppression than omeprazole 2

However, the guidelines emphasize there is no dose-response relationship for PPIs in functional dyspepsia—use the lowest effective dose 1

Step 3: Second-Line Treatment with Tricyclic Antidepressants

If symptoms persist after H. pylori eradication (or if H. pylori negative), initiate a tricyclic antidepressant 1:

• Amitriptyline 10 mg once daily at bedtime, titrated slowly to 30-50 mg once daily as tolerated

• This is a strong recommendation with moderate-quality evidence for functional dyspepsia 1

• Critical counseling point: Explain this is used as a "gut-brain neuromodulator" to reduce visceral hypersensitivity, NOT for depression. This explanation improves adherence 1

• Warn about side effects: dry mouth, constipation, drowsiness, urinary retention

• Continue for 6-12 months if effective 4

Step 4: Alternative Second-Line Options

If TCAs are contraindicated or not tolerated:

• Prokinetics (if available): Tegaserod has moderate-quality evidence (strong recommendation), while acotiamide, itopride, and mosapride have low-quality evidence (weak recommendation) 1. Many are unavailable outside Asia/USA

• Antipsychotics: Sulpiride 100 mg QID or levosulpiride 25 mg TID may be efficacious but require careful counseling about rationale and side effects 1

Lifestyle Modifications

Recommend regular aerobic exercise—this is a strong recommendation despite very low-quality evidence 1. The risk-benefit ratio strongly favors this intervention.

Do NOT recommend restrictive diets (including low-FODMAP) as there is insufficient evidence to support dietary therapies in functional dyspepsia 1

Common Pitfalls to Avoid

1. Continuing omeprazole indefinitely without reassessment: Long-term PPI use (>3 years) carries risks including hypomagnesemia, vitamin B12 deficiency, bone fractures, acute interstitial nephritis, and Clostridium difficile infection 3

2. Ordering unnecessary tests: Gastric emptying studies and pH monitoring do not change management in typical functional dyspepsia 1

3. Failing to explain TCA rationale: Patients often refuse antidepressants if they don't understand they're being used for visceral pain modulation, not psychiatric illness 1

4. Using opioids: These should be strictly avoided in functional dyspepsia to minimize iatrogenic harm 1

5. Ignoring eating disorders: If the patient develops weight loss or food restriction, assess for avoidant restrictive food intake disorder (ARFID) 1

When to Refer

Refer to gastroenterology if 1:

• Diagnostic uncertainty remains
• Symptoms are severe or refractory to second-line treatments
• Patient requests specialist opinion
• Ideally, manage in a specialist functional GI clinic with access to dietetic support and gut-brain behavioral therapies

Duration Considerations

The evidence shows that early response predicts long-term response: patients who don't improve within the first week of PPI therapy are unlikely to respond at 4 weeks 5. Since your patient has been on omeprazole "since [DATE]" without adequate relief, continuing the same approach is futile—move to H. pylori testing and second-line therapy.